Entry
Name
Relaxin signaling pathway - Capra hircus (goat)
Description
Human relaxin-2 ("relaxin"), originally identified as a peptidic hormone of pregnancy, is now known to exert a range of pleiotropic effects including vasodilatory, anti-fibrotic and angiogenic effects in both males and females. It belongs to the so-called relaxin peptide family which includes the insulin-like peptides INSL3 and INSL5, and relaxin-3 (H3) as well as relaxin. INSL3 has clearly defined specialist roles in male and female reproduction, relaxin-3 is primarily a neuropeptide involved in stress and metabolic control, and INSL5 is widely distributed particularly in the gastrointestinal tract. These members of relaxin peptide family exert such effects binding to different kinds of receptors, classified as relaxin family peptide (RXFP) receptors: RXFP1, RXFP2, RXFP3, and RXFP4. These G protein-coupled receptors predominantly bind relaxin, INSL3, relaxin-3, and INSL-5, respectively. RXFP1 activates a wide spectrum of signaling pathways to generate second messengers that include cAMP and nitric oxide, whereas RXFP2 activates a subset of these pathways. Both RXFP3 and RXFP4 inhibit cAMP production, and RXFP3 activate MAP kinases.
Class
Organismal Systems; Endocrine system
BRITE hierarchy
Pathway map
Ortholog table
Organism
Capra hircus (goat) [GN:
chx ]
Gene
102186145 GNAO1; guanine nucleotide-binding protein G(o) subunit alpha isoform X1 [KO:K04534 ]
100860765 GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630 ]
102185804 GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630 ]
108635583 GNAI3; guanine nucleotide-binding protein G(k) subunit alpha [KO:K04630 ]
102188874 guanine nucleotide-binding protein G(s) subunit alpha isoforms short isoform X1 [KO:K04632 ]
102187070 GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536 ]
102169841 GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 [KO:K07825 ]
102191178 GNB4; guanine nucleotide-binding protein subunit beta-4 [KO:K04538 ]
102174574 GNB5; guanine nucleotide-binding protein subunit beta-5 [KO:K04539 ]
102189312 GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 isoform X2 [KO:K07826 ]
102184123 GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 [KO:K04540 ]
102170665 GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 [KO:K04541 ]
102190485 GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [KO:K04542 ]
102183232 GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [KO:K04543 ]
102189040 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545 ]
106502450 GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545 ]
102186081 GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546 ]
102175543 GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO:K04347 ]
102190190 GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 isoform X2 [KO:K04547 ]
102185427 GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1 [KO:K04548 ]
102190164 GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 [KO:K04549 ]
102186065 CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870 ]
102180634 ATF2; LOW QUALITY PROTEIN: cyclic AMP-dependent transcription factor ATF-2 [KO:K04450 ]
102185072 ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374 ]
102180221 CREB3; cyclic AMP-responsive element-binding protein 3 isoform X1 [KO:K09048 ]
102174829 CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1 [KO:K09048 ]
102183745 CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 isoform X1 [KO:K09048 ]
102183893 CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048 ]
102170199 CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048 ]
102190378 CREB5; cyclic AMP-responsive element-binding protein 5 isoform X1 [KO:K09047 ]
102171671 ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta isoform X1 [KO:K09049 ]
100860957 VEGFA; vascular endothelial growth factor A isoform 1 precursor [KO:K05448 ]
102189099 VEGFB; vascular endothelial growth factor B isoform X1 [KO:K16858 ]
102175660 NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580 ]
102185042 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922 ] [EC:2.7.1.153 ]
102168391 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922 ] [EC:2.7.1.153 ]
102177551 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
102179343 PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649 ]
102170135 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta isoform X1 [KO:K02649 ]
102188710 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649 ]
102191364 TGFB1; transforming growth factor beta-1 proprotein precursor [KO:K13375 ]
102188455 SMAD2; mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500 ]
102171079 COL4A1; LOW QUALITY PROTEIN: collagen alpha-1(IV) chain [KO:K06237 ]
102188148 PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858 ] [EC:3.1.4.11 ]
102180505 PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858 ] [EC:3.1.4.11 ]
102169966 PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858 ] [EC:3.1.4.11 ]
102169956 SHC2; LOW QUALITY PROTEIN: SHC-transforming protein 2 [KO:K17447 ]
102177052 GNA15; guanine nucleotide-binding protein subunit alpha-15 isoform X1 [KO:K04637 ]
Compound
C01245 D-myo-Inositol 1,4,5-trisphosphate
C05981 Phosphatidylinositol-3,4,5-trisphosphate
Reference
Authors
Bathgate RA, Halls ML, van der Westhuizen ET, Callander GE, Kocan M, Summers RJ
Title
Relaxin family peptides and their receptors.
Journal
Reference
Authors
Cernaro V, Lacquaniti A, Lupica R, Buemi A, Trimboli D, Giorgianni G, Bolignano D, Buemi M
Title
Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein.
Journal
Reference
Authors
van der Westhuizen ET, Halls ML, Samuel CS, Bathgate RA, Unemori EN, Sutton SW, Summers RJ
Title
Relaxin family peptide receptors--from orphans to therapeutic targets.
Journal
Reference
Authors
Halls ML, van der Westhuizen ET, Bathgate RA, Summers RJ
Title
Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
Journal
Reference
Authors
Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ
Title
International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
Journal
Reference
Authors
Du XJ, Bathgate RA, Samuel CS, Dart AM, Summers RJ
Title
Cardiovascular effects of relaxin: from basic science to clinical therapy.
Journal
Reference
Authors
Nistri S, Bani D
Title
Relaxin receptors and nitric oxide synthases: search for the missing link.
Journal
Reference
Authors
Samuel CS, Hewitson TD, Unemori EN, Tang ML
Title
Drugs of the future: the hormone relaxin.
Journal
Reference
Authors
Sasser JM
Title
The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.
Journal
Reference
Authors
Sarwar M, Du XJ, Dschietzig TB, Summers RJ
Title
The actions of relaxin on the human cardiovascular system.
Journal
Reference
Authors
Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ
Title
Receptors for relaxin family peptides.
Journal
Reference
Authors
Chow BS, Chew EG, Zhao C, Bathgate RA, Hewitson TD, Samuel CS
Title
Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.
Journal
Reference
Authors
Samuel CS, Du XJ, Bathgate RA, Summers RJ
Title
'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease.
Journal
Reference
Authors
Wilson SS, Ayaz SI, Levy PD
Title
Relaxin: a novel agent for the treatment of acute heart failure.
Journal
Reference
Authors
Halls ML, Bathgate RA, Summers RJ
Title
Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms.
Journal
Reference
Authors
Kocan M, Ang SY, Summers RJ
Title
Orthosteric, Allosteric and Biased Signalling at the Relaxin-3 Receptor RXFP3.
Journal
Reference
Authors
van der Westhuizen ET, Werry TD, Sexton PM, Summers RJ
Title
The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
Journal
Related pathway
chx04270 Vascular smooth muscle contraction
KO pathway
LinkDB
All DBs